$1.87
0.021.08%
At close: -
$1.80
-0.07-3.74%
After Hours: Apr 25, 9:07 AM EDT
Comments
Loading...
BioXcel Therapeutics Insider Trading Activity | NASDAQ:BTAI | Benzinga
Track the latest BioXcel Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for BioXcel Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are BioXcel Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for BioXcel Therapeutics Inc
Shares Outstanding
5.468M
Insider Shares Owned
176.169K
Insider Percentage Owned
3.21%
Institutional Shares Held
1.014M
Institutional Percentage Held
1.75%
| Dec 17, 2024 | Vincent O'Neill | SEE REMARKS | 356.00 | $0.35 | -$58.13 | SELL-OPTIONS | 1.82% | 19.96K | Dec 14 - Dec 16 | View |
| Dec 17, 2024 | Vimal Mehta | CEO AND PRESIDENT | 2.99K | $0.36 | -$1.13K | SELL-OPTIONS | 0.04% | 7.75M | Dec 14 - Dec 16 | View |
| Dec 17, 2024 | Richard Steinhart | CHIEF FINANCIAL OFFICER | 506.00 | $0.36 | -$206.98 | SELL-OPTIONS | 2.48% | 20.93K | Dec 14 - Dec 16 | View |
| Dec 17, 2024 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | 653.00 | $0.35 | -$151.82 | SELL-OPTIONS | 2.31% | 28.93K | Dec 14 - Dec 16 | View |
| Oct 03, 2024 | Matthew Wiley | CHIEF COMMERCIAL OFFICER | 14.98K | $0.55 | -$3.45K | GRANT | 371.39% | 19.01K | Sep 17 - Oct 03 | View |
| Oct 03, 2024 | Javier Rodriguez | SEE REMARKS | 14.39K | $0.55 | -$3.77K | GRANT | 153.33% | 23.77K | Sep 17 - Oct 03 | View |
| Oct 03, 2024 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | 14.07K | $0.55 | -$3.95K | GRANT | 99.10% | 28.28K | Sep 17 - Oct 03 | View |
| Oct 03, 2024 | Richard Steinhart | CHIEF FINANCIAL OFFICER | 14.07K | $0.55 | -$3.95K | GRANT | 226.87% | 20.28K | Sep 17 - Oct 03 | View |
| Oct 03, 2024 | Vincent O'Neill | SEE REMARKS | 15.69K | $0.55 | -$3.06K | GRANT | 401.69% | 19.60K | Sep 17 - Oct 03 | View |
| Sep 17, 2024 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | 729.00 | $0.69 | -$244.70 | SELL-OPTIONS | 5.41% | 14.20K | Sep 14 - Sep 16 | View |
| Sep 17, 2024 | Vimal Mehta | CEO AND PRESIDENT | 4.13K | $0.69 | -$1.37K | SELL-OPTIONS | 0.05% | 7.74M | Sep 14 - Sep 16 | View |
| Sep 17, 2024 | Richard Steinhart | CHIEF FINANCIAL OFFICER | 728.00 | $0.69 | -$245.60 | SELL-OPTIONS | 13.29% | 6.20K | Sep 14 - Sep 16 | View |
| Sep 17, 2024 | Javier Rodriguez | SEE REMARKS | 739.00 | $0.69 | -$238.05 | SELL-OPTIONS | 8.80% | 9.13K | Sep 14 - Sep 16 | View |
| Sep 17, 2024 | Vincent O'Neill | SEE REMARKS | 383.00 | $0.69 | -$95.33 | SELL-OPTIONS | 10.87% | 3.91K | Sep 14 - Sep 16 | View |
| Sep 17, 2024 | Matthew T Wiley | CHIEF COMMERCIAL OFFICER | 535.00 | $0.69 | -$148.52 | SELL-OPTIONS | 15.29% | 4.03K | Sep 15 - Sep 16 | View |
| Jun 18, 2024 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | 711.00 | $1.28 | -$476.16 | SELL-OPTIONS | 5.57% | 13.47K | Jun 14 - Jun 17 | View |
| Jun 18, 2024 | Matthew T Wiley | CHIEF COMMERCIAL OFFICER | 506.00 | $1.26 | -$308.10 | SELL-OPTIONS | 16.91% | 3.50K | Jun 15 - Jun 17 | View |
| Jun 18, 2024 | Richard Steinhart | CHIEF FINANCIAL OFFICER | 711.00 | $1.26 | -$469.54 | SELL-OPTIONS | 14.92% | 5.48K | Jun 14 - Jun 17 | View |
| Jun 18, 2024 | Javier Rodriguez | SEE REMARKS | 722.00 | $1.26 | -$456.02 | SELL-OPTIONS | 9.41% | 8.39K | Jun 14 - Jun 17 | View |
| Jun 18, 2024 | Vincent O'Neill | SEE REMARKS | 366.00 | $1.28 | -$199.17 | SELL-OPTIONS | 11.59% | 3.52K | Jun 14 - Jun 17 | View |
| Jun 18, 2024 | Vimal Mehta | CEO AND PRESIDENT | 3.98K | $1.28 | -$2.74K | SELL-OPTIONS | 0.05% | 7.73M | Jun 14 - Jun 17 | View |
| Jun 06, 2024 | Vimal MehtaBioXcel Holdings IncBioXcel LLC | CEO AND PRESIDENT | -1.43M | $1.61 | -$405.14K | SELL | -15.66% | 7.69M | Jun 04 - Jun 05 | View |
| Apr 08, 2024 | Vincent O'Neill | SEE REMARKS | 2.61K | $2.62 | -$432.48 | SELL-OPTIONS | 93.00% | 5.41K | Mar 14 - Apr 04 | View |
| Apr 08, 2024 | Vimal Mehta | CEO AND PRESIDENT | 11.34K | $2.62 | -$13.82K | SELL-OPTIONS | 0.13% | 8.59M | Mar 14 - Apr 04 | View |
| Apr 08, 2024 | Richard Steinhart | CHIEF FINANCIAL OFFICER | 1.70K | $2.63 | -$2.82K | SELL-OPTIONS | 55.57% | 4.76K | Mar 14 - Apr 04 | View |
| Apr 08, 2024 | Matthew T Wiley | CHIEF COMMERCIAL OFFICER | 1.99K | $2.64 | -$2.66K | SELL-OPTIONS | 199.20% | 2.99K | Mar 15 - Apr 04 | View |
| Apr 08, 2024 | Javier Rodriguez | SEE REMARKS | 1.76K | $2.64 | -$2.67K | SELL-OPTIONS | 29.75% | 7.67K | Mar 14 - Apr 04 | View |
| Apr 08, 2024 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | 1.70K | $2.63 | -$2.81K | SELL-OPTIONS | 15.41% | 12.76K | Mar 14 - Apr 04 | View |
| Jun 16, 2023 | Vimal Mehta | CEO AND PRESIDENT | 2.61K | $10.64 | -$1.23M | SELL-OPTIONS | 6.64% | 41.90K | Jun 14 - Jun 16 | View |
| May 24, 2023 | Vimal Mehta | CEO AND PRESIDENT | -6.50K | $25.79 | -$167.64K | SELL | -14.19% | 39.29K | May 22 | View |
| May 16, 2023 | Richard Steinhart | CHIEF FINANCIAL OFFICER | 0.00 | $27.17 | -$135.86K | SELL-OPTIONS | 0.00% | 1.50K | May 14 - May 15 | View |
| May 16, 2023 | Javier Rodriguez | SEE REMARKS | 3.21K | $27.32 | -$48.76K | SELL-OPTIONS | 283.26% | 4.35K | May 14 - May 15 | View |
| Apr 10, 2023 | Krishnan Nandabalan | DIRECTOR | 0.00 | $8.87 | -$1.01M | SELL-OPTIONS | 0.00% | 8.55M | Apr 06 | View |
| Mar 22, 2023 | Vimal Mehta | CEO AND PRESIDENT | -4.50K | $9.69 | -$1.20M | SELL | -20.09% | 17.89K | Mar 20 - Mar 21 | View |
| Mar 16, 2023 | Richard Steinhart | CHIEF FINANCIAL OFFICER | 0.00 | $19.50 | -$40.64K | SELL-OPTIONS | 0.00% | 1.50K | Mar 14 - Mar 15 | View |
| Mar 16, 2023 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | 1.10K | $19.69 | -$19.40K | SELL-OPTIONS | 13.09% | 9.50K | Mar 14 - Mar 15 | View |
| Mar 16, 2023 | Vincent O'Neill | CHIEF MEDICAL OFFICER | 1.24K | $19.70 | -$16.64K | SELL-OPTIONS | ∞ | 1.24K | Mar 14 - Mar 15 | View |
| Mar 16, 2023 | Javier Rodriguez | SEE REMARKS | 1.13K | $19.63 | -$18.64K | SELL-OPTIONS | 113400.00% | 1.14K | Mar 14 - Mar 15 | View |
| Jan 24, 2023 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | -50.00K | $30.00 | -$1.50M | SELL | -85.62% | 8.40K | Jan 20 | View |
| Jan 24, 2023 | Vincent O'Neill | CHIEF MEDICAL OFFICER | 0.00 | $15.21 | -$879.21K | SELL-OPTIONS | 0.00% | 0.00 | Jan 20 | View |
| Jan 06, 2023 | Krishnan Nandabalan | DIRECTOR | 0.00 | $11.21 | -$1.30M | SELL-OPTIONS | 0.00% | 8.55M | Jan 04 - Jan 05 | View |
| Dec 19, 2022 | Vimal Mehta | CEO AND PRESIDENT | 0.00 | $10.05 | -$1.16M | SELL-OPTIONS | 0.00% | 11.96K | Dec 15 - Dec 16 | View |
| Nov 14, 2022 | Krishnan Nandabalan | DIRECTOR | 0.00 | $7.71 | -$875.40K | SELL-OPTIONS | 0.00% | 8.55M | Nov 10 - Nov 11 | View |
| Jun 29, 2021 | Vimal Mehta | CEO, PRESIDENT AND SECRETARY | -473.25K | $30.83 | -$14.59M | SELL | -5.24% | 8.56M | Jun 25 | View |
| Jun 29, 2021 | Krishnan Nandabalan | DIRECTOR | -473.25K | $30.83 | -$14.59M | SELL | -5.25% | 8.55M | Jun 25 | View |
| Jun 29, 2021 | BioXcel LLC | 10% OWNER | -473.25K | $30.83 | -$14.59M | SELL | -5.25% | 8.55M | Jun 25 | View |
| Jun 29, 2021 | BioXcel Holdings Inc | 10% OWNER | -473.25K | $30.83 | -$14.59M | SELL | -5.25% | 8.55M | Jun 25 | View |
| Mar 17, 2021 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | -15.00K | $48.50 | -$727.57K | SELL | -20.44% | 58.40K | Mar 15 | View |
| Feb 19, 2021 | Vincent O'Neill | CHIEF MEDICAL OFFICER | 0.00 | $30.11 | -$1.27M | SELL-OPTIONS | 0.00% | 0.00 | Feb 17 | View |
| Feb 18, 2021 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | -15.00K | $57.68 | -$865.15K | SELL | -16.97% | 73.40K | Feb 16 | View |
| Feb 16, 2021 | Vimal Mehta | CEO, PRESIDENT AND SECRETARY | -78.00K | $60.15 | -$4.84M | DISPOSITION | -49.37% | 80.00K | Mar 12 - Jul 24 | View |
| Feb 03, 2021 | Richard I Steinhart | CHIEF FINANCIAL OFFICER | 0.00 | $26.85 | -$159.75K | SELL-OPTIONS | 0.00% | 1.50K | Feb 01 | View |
| Jan 27, 2021 | Frank Yocca | CHIEF SCIENTIFIC OFFICER | 0.00 | $24.40 | -$719.66K | SELL-OPTIONS | 0.00% | 88.40K | Jan 25 | View |
| Jan 21, 2021 | Vincent O'Neill | CHIEF MEDICAL OFFICER | 0.00 | $24.94 | -$1.23M | SELL-OPTIONS | 0.00% | 0.00 | Jan 19 | View |
| Dec 30, 2020 | Vincent O'Neill | — | 0.00 | $25.93 | -$1.28M | OPTION EXERCISE | 0.00% | 0.00 | Dec 28 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
